SAB Biotherapeutics Inc
SABS3.840USD
-0.150-3.76%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
182.38MMarket Cap
LossP/E TTM
SAB Biotherapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
1.32M
-40.94%
EPS(YoY)
-3.68
51.81%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its total revenue reached 1.32M, with a year-on-year change of -40.94%.
What is the Earnings Per Share (EPS) of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -3.682, with a year-on-year change of 51.81%.
What is the net income of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its net income was -34.11M, with a year-on-year change of 19.17%.
What is the net margin of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its net profit margin was -2579.03%, with a year-on-year change of -36.85%.
What is the gross margin of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 8.36%, with a year-on-year change of 52.49%.
What is the Return on Equity (ROE) of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -81.92%, with a year-on-year change of 14.23%.
What is the Return on Assets (ROA) of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -53.23%, with a year-on-year change of 14.94%.
What is the operating profit of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its operating profit was -42.81M, with a year-on-year change of -12.73%.
What are the current assets of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its current assets were 23.79M, with a year-on-year change of -59.61%.
What are the total assets of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its total assets of SAB Biotherapeutics Inc were 44.20M, with a year-on-year change of -47.35%.
What are the total liabilities of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its total liabilities of SAB Biotherapeutics Inc were 18.23M, with a year-on-year change of -31.59%.
What is the total equity of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its total equity of SAB Biotherapeutics Inc was 25.97M, with a year-on-year change of -54.68%.
What is the net operating income of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its net operating income of SAB Biotherapeutics Inc was -34.11M, with a year-on-year change of 19.17%.
What is the net investment of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its net investment of SAB Biotherapeutics Inc was -11.96M, with a year-on-year change of -7733.63%.
What is the net financing of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2024 earnings report, its net financing of SAB Biotherapeutics Inc was -1.17M, with a year-on-year change of -101.76%.
